Methods for optimizing antiviral combination therapies
暂无分享,去创建一个
Thomas Lengauer | Joachim Selbig | Niko Beerenwinkel | Hauke Walter | Rolf Kaiser | Daniel Hoffmann | Klaus Korn | Martin Däumer | Thomas Lengauer | J. Selbig | N. Beerenwinkel | H. Walter | R. Kaiser | D. Hoffmann | K. Korn | M. Däumer
[1] G. Bocharov,et al. Recombination: Multiply infected spleen cells in HIV patients , 2002, Nature.
[2] Chris Hyde,et al. Systematic review and meta-analysis of evidence for increasing numbers of drugs in antiretroviral combination therapy , 2002, BMJ : British Medical Journal.
[3] A. Telenti,et al. HIV treatment failure: testing for HIV resistance in clinical practice. , 1998, Science.
[4] Steven Skiena,et al. Deconvolving Sequence Variation in Mixed DNA Populations , 2003, J. Comput. Biol..
[5] Richard H. Lathrop,et al. Knowledge-Based Avoidance of Drug-Resistant HIV Mutants , 1998, AI Mag..
[6] B. Schmidt,et al. Rapid, phenotypic HIV-1 drug sensitivity assay for protease and reverse transcriptase inhibitors. , 1999, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[7] E. De Clercq,et al. Managing resistance to anti-HIV drugs: an important consideration for effective disease management. , 1999, Drugs.
[8] Richard H. Lathrop,et al. Combinatorial Optimization in Rapidly Mutating Drug-Resistant Viruses , 1999, J. Comb. Optim..
[9] J. Holland,et al. RNA virus populations as quasispecies. , 1992, Current topics in microbiology and immunology.
[10] Eric R. Ziegel,et al. The Elements of Statistical Learning , 2003, Technometrics.
[11] Thomas Lengauer,et al. Quantitative phenotype prediction by support vector machines , 2002 .
[12] Thomas Lengauer,et al. Geno2pheno: Interpreting Genotypic HIV Drug Resistance Tests , 2001, IEEE Intell. Syst..
[13] A. Jetzt,et al. High Rate of Recombination throughout the Human Immunodeficiency Virus Type 1 Genome , 2000, Journal of Virology.
[14] Rami Kantor,et al. The Genetic Basis of HIV-1 Resistance to Reverse Transcriptase and Protease Inhibitors. , 2000, AIDS reviews.
[15] R. Laufs,et al. Primary genotypic resistance of HIV-1 to the fusion inhibitor T-20 in long-term infected patients. , 2001, AIDS.
[16] S. Hammer,et al. The Relation between Baseline HIV Drug Resistance and Response to Antiretroviral Therapy: Re-Analysis of Retrospective and Prospective Studies Using a Standardized Data Analysis Plan , 2000, Antiviral therapy.
[17] Thomas Lengauer,et al. Diversity and complexity of HIV-1 drug resistance: A bioinformatics approach to predicting phenotype from genotype , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[18] Thomas Lengauer,et al. Geno2pheno is predictive of short-term virological response , 2002 .
[19] J. Schapiro,et al. Methods for investigation of the relationship between drug-susceptibility phenotype and human immunodeficiency virus type 1 genotype with applications to AIDS clinical trials group 333. , 2000, The Journal of infectious diseases.